Quantcast
Last updated on April 21, 2014 at 7:45 EDT

Latest Peyronie's disease Stories

2013-05-28 08:29:09

LYNBROOK, N.Y., May 28, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in-class collagenase-based products marketed as XIAFLEX® in the U.S., today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the upcoming Jefferies 2013 Global Healthcare Conference at 10:00 a.m. EDT on Monday, June 3, 2013 in New York, NY. The live webcast of this presentation can be accessed under "Calendar...

2013-05-24 08:22:32

CHESTERBROOK, Pa., May 24, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Deutsche Bank Health Care Conference to be held May 29-30 at the Westin Boston Waterfront Hotel. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 12:00 p.m. ET on Wednesday, May 29, 2013. (Logo:...

2013-05-15 08:29:51

CHESTERBROOK, Pa., May 15, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the UBS Global Health Care Conference to be held May 20-22 at the Sheraton New York Hotel. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 3:00 p.m. ET on Wednesday, May 21, 2013. (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The...

2013-05-10 16:25:09

CHESTERBROOK, Pa., May 10, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Bank of America Merrill Lynch 2013 Health Care Conference to be held May 14-16 at the Encore at the Wynn Las Vegas. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 3:00 p.m. PT (6:00 pm ET) on Wednesday, May 15, 2013. (Logo:...

2013-05-10 08:24:32

LYNBROOK, N.Y., May 10, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products marketed as XIAFLEX® in the U.S., today reported its financial results for the first quarter ended March 31, 2013 and provided a corporate update. "We are very pleased to have completed enrollment in our Phase II trials in canine and human lipoma and we remain on track to report top-line data for both trials...

2013-05-03 08:25:37

LYNBROOK, N.Y., May 3, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S., announced today that it will host a conference call and live audio webcast at 8:30 a.m. EDT on Friday, May 10, 2013 to report its first quarter 2013 financial results and provide a corporate update. In order to participate in the conference call, please dial 1-800-860-2442...

2013-04-29 08:26:56

-Transaction Expected to be Immediately Accretive to Adjusted Non-GAAP Net Income- CHESTERBROOK, Pa. and LAKE FOREST, Ill., April 29, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that it has completed the acquisition of Actient Holdings LLC ("Actient"), a private urology specialty therapeutics company, for $585 million in upfront cash plus certain contingent consideration and warrants to purchase Auxilium...

2013-04-29 08:26:50

- 1Q13 Net Revenues Decreased by 10% from 1Q12 to $66.2 MM - CHESTERBROOK, Pa., April 29, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, today announced financial results for the first quarter ending on March 31, 2013. The Company also highlighted important recent commercial, regulatory and clinical development progress in the first quarter of 2013. (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) For the...

2013-04-25 16:30:46

CHESTERBROOK, Pa., April 25, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the first quarter 2013 on Monday, April 29, 2013 before the opening of the U.S. financial markets. The Company will also conduct a conference call that day at 8:30 a.m. ET to discuss results and highlights of the first quarter. The presentation slides to be used during the call will be available on the "For Investors" section of the...

2013-03-26 08:29:25

LYNBROOK, N.Y., March 26, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S., today announced positive, statistically significant top-line data from the Phase IIa study of XIAFLEX for the potential treatment of frozen shoulder (adhesive capsulitis). "We are very encouraged by these positive results and look forward to progress in this program which...